Wellcome Trust grant boosts Novartis's typhoid vaccine R&D
05 June 2009
Becky Debens
A new vaccine tackling two strains of typhoid in both adults and children may hold the potential to eradicate the disease,
Novartis has claimed.
The UK charity
Wellcome Trust has granted €5.15 million to Novartis's non-profit vaccine development arm, Novartis Vaccines Institute...
Please Login to read the full article.